VIRIDIAN THERAPEUTICS INC (VRDN)

US92790C1045 - Common Stock

15.4  +0.82 (+5.62%)

After market: 16.3 +0.9 (+5.84%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
314.00K1.77M2.96M1.05M4.46M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
254.76M136.08M82.69M41.27M44.44M
Research and Development
159.26M100.59M56.79M27.80M32.81M
Selling, General, and Administrative Expenses
95.00M35.18M25.81M13.27M11.35M
Operating Income
-254.45M-134.30M-79.73M-40.22M-39.98M
Interest Income/Expense
16.72M4.43M320.00K-340.00K110.00K
Non Recurring Items
N/AN/A0.00-70.16M-2.00M
Income Before Taxes
-237.73M-129.87M-79.41M-110.72M-41.87M
Net Income
-237.73M-129.87M-79.41M-110.72M-41.87M
EBITDA
-253.93M-134.04M-79.61M-39.98M-39.69M
 
Per Share Data
EPS Diluted Total Ops
-5.31-4.05-6.66-31.10-20.04
Non GAAP EPS
-5.32-4.03-7.69-11.31-20.10
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-75711.46%-7337.29%-2682.77%-10544.76%-938.79%
Operating Profit Margin
-81035.03%-7587.57%-2693.58%-3830.48%-896.41%

All data in USD

Charts